HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Pheochromocytoma

Pheochromocytoma

Pheochromocytoma, a rare tumor of the adrenal glands, presents unique challenges in cancer research. These tumors, though usually benign, can be malignant and secrete excessive amounts of adrenaline, leading to severe hypertension and other life-threatening complications. Understanding the genetic underpinnings of pheochromocytoma is crucial for tailored treatment approaches. Recent research focuses on identifying genetic mutations, such as those in the RET, VHL, and SDH genes, which predispose individuals to this condition. Advances in imaging techniques aid in early detection and precise surgical removal, improving patient outcomes. Moreover, exploring novel targeted therapies and immunotherapies offers hope for more effective treatments, particularly for metastatic or recurrent cases. Collaborative efforts between clinicians, geneticists, and researchers are essential to unravel the complexities of pheochromocytoma and develop personalized strategies for management.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Saumya Pandey

Saumya Pandey

Indira IVF Hospital, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp